Auro Laboratories Limited | Small-cap | Healthcare
₹220.50
-3.33%
| Auro Laboratories Stock Comparison:
Auro Laboratories vs Sun PharmaceuticalAuro Laboratories vs Divi's LaboratoriesAuro Laboratories vs Innova CaptabAuro Laboratories vs Suven Life SciencesAuro Laboratories vs Gujarat ThemisAuro Laboratories vs NIFTY 50 | Market
TL;DR Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Jun 2025

Income Metrics

Revenue 27.7M
Gross Profit 18.7M 67.54%
Operating Income -2.4M -8.69%
Net Income -1.1M -3.80%
EPS (Diluted) ₹-0.17

Balance Sheet Metrics

Total Assets 991.0M
Total Liabilities 561.3M
Shareholders Equity 429.7M
Debt to Equity 1.31

Cash Flow Metrics

Revenue & Profitability Trend

Auro Laboratories Income Statement From 2021 to 2025

Metric20252024202320222021
Revenue i191.2M527.0M522.6M504.4M529.3M
Cost of Goods Sold i99.1M277.6M367.3M335.8M298.4M
Gross Profit i92.2M249.4M155.4M168.6M231.0M
Gross Margin % i48.2%47.3%29.7%33.4%43.6%
Operating Expenses
Research & Development i-----
Selling, General & Administrative i5.7M14.8M11.9M9.9M13.2M
Other Operating Expenses i30.5M85.8M58.6M54.3M58.2M
Total Operating Expenses i36.2M100.6M70.5M64.2M71.4M
Operating Income i23.1M95.8M33.2M36.1M102.1M
Operating Margin % i12.1%18.2%6.4%7.2%19.3%
Non-Operating Items
Interest Income i715.0K665.0K1.0M3.5M1.8M
Interest Expense i10.8M7.4M8.1M8.3M4.6M
Other Non-Operating Income-----
Pre-tax Income i18.8M103.5M34.5M38.7M105.1M
Income Tax i421.0K25.5M10.0M10.3M33.3M
Effective Tax Rate % i2.2%24.7%29.1%26.6%31.7%
Net Income i18.4M77.9M24.4M28.4M71.8M
Net Margin % i9.6%14.8%4.7%5.6%13.6%
Key Metrics
EBITDA i40.6M121.7M53.3M56.7M120.0M
EPS (Basic) i₹2.95₹12.50₹3.92₹4.56₹11.52
EPS (Diluted) i₹2.95₹12.50₹3.92₹4.56₹11.52
Basic Shares Outstanding i62325006232500623250062325006232500
Diluted Shares Outstanding i62325006232500623250062325006232500

Income Statement Trend

Auro Laboratories Balance Sheet From 2021 to 2025

Metric20252024202320222021
Assets
Current Assets
Cash & Equivalents i3.0K9.9M17.9M52.1M108.2M
Short-term Investments i18.7M4.7M28.6M65.7M30.0M
Accounts Receivable i93.9M133.9M124.0M136.1M73.0M
Inventory i36.7M82.4M117.6M42.5M25.5M
Other Current Assets-----
Total Current Assets i215.1M308.5M356.6M376.3M281.5M
Non-Current Assets
Property, Plant & Equipment i16.5M16.5M16.5M16.5M16.5M
Goodwill i-----
Intangible Assets i-----
Long-term Investments-----
Other Non-Current Assets-----
Total Non-Current Assets i775.8M548.8M203.3M173.3M137.4M
Total Assets i991.0M857.3M559.9M549.6M418.9M
Liabilities
Current Liabilities
Accounts Payable i62.1M62.0M114.8M48.6M57.5M
Short-term Debt i119.3M78.7M44.0M121.2M7.7M
Current Portion of Long-term Debt-----
Other Current Liabilities34.0M8.3M11.9M16.4M16.7M
Total Current Liabilities i216.4M239.3M181.3M201.3M92.4M
Non-Current Liabilities
Long-term Debt i330.9M183.8M20.1M16.6M23.9M
Deferred Tax Liabilities i14.0M14.6M16.5M16.5M16.8M
Other Non-Current Liabilities-1.0K-95.0K-1.0K--
Total Non-Current Liabilities i344.9M198.3M36.6M33.1M40.7M
Total Liabilities i561.3M437.7M217.9M234.4M133.1M
Equity
Common Stock i62.3M62.3M62.3M62.3M62.3M
Retained Earnings i359.5M347.5M269.5M245.1M216.8M
Treasury Stock i-----
Other Equity-----
Total Shareholders Equity i429.7M419.7M342.0M315.2M285.8M
Key Metrics
Total Debt i450.1M262.4M64.1M137.8M31.6M
Working Capital i-1.3M69.2M175.3M175.0M189.2M

Balance Sheet Composition

Auro Laboratories Cash Flow Statement From 2021 to 2025

Metric20252024202320222021
Operating Activities
Net Income i18.8M103.5M34.5M38.7M105.1M
Depreciation & Amortization i-----
Stock-Based Compensation i-----
Working Capital Changes i47.3M98.4M-84.6M-116.5M-9.9M
Operating Cash Flow i74.2M211.7M-39.6M-71.9M98.1M
Investing Activities
Capital Expenditures i20.0K000-
Acquisitions i-----
Investment Purchases i-----
Investment Sales i-----
Investing Cash Flow i-7.2M-31.0M-11.1M-10.8M-33.1M
Financing Activities
Share Repurchases i-----
Dividends Paid i-----
Debt Issuance i147.1M166.2M9.1M00
Debt Repayment i0-3.3M-82.7M-7.3M-6.6M
Financing Cash Flow i187.7M195.0M-156.4M103.1M-2.2M
Free Cash Flow i-180.5M-168.3M-7.9M-112.0M124.4M
Net Change in Cash i254.6M375.8M-207.1M20.4M62.7M

Cash Flow Trend

Auro Laboratories Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 145.29
Price to Book 3.32
Price to Sales 8.64
PEG Ratio -1.27

Profitability Ratios

Profit Margin 5.96%
Operating Margin -8.69%
Return on Equity 4.28%
Return on Assets 1.86%

Financial Health

Current Ratio 0.99
Debt to Equity 104.76
Beta 0.20

Per Share Data

EPS (TTM) ₹1.57
Book Value per Share ₹68.67
Revenue per Share ₹26.41

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
aurolab1.5B145.293.324.28%5.96%104.76
Sun Pharmaceutical 4.0T37.735.4215.08%19.29%3.26
Divi's Laboratories 1.6T67.5710.4014.64%23.89%0.03
Innova Captab 48.6B37.445.0713.37%9.98%35.24
Suven Life Sciences 48.0B-28.3141.36-146.15%84.44%0.00
Gujarat Themis 46.2B103.1518.5519.64%30.17%12.27

Financial data is updated regularly. All figures are in the company's reporting currency.